Panag Pharma Completes Phase 3 Trial With Awaye™

    NEXT STORY
    G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference
    PREV STORY
    ELSAH-PROJEKT SETZT NEUE MASSSTÄBE BEI WEARABLES
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

    author_avatar
    NASDAQ Market News

    BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements

    author_avatar
    NASDAQ Market News

    Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

    Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project ...

    author_avatar
    NASDAQ Market News